From my colleague Elaine Chen: Wave Life Sciences said today that interim data show its investigational siRNA therapy cut ...

Could a dusty rock hurtling through space hold the recipe for life? NASA’s latest analysis of asteroid Bennu’s pristine ...

Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

We came across a bullish thesis on Wave Life Sciences Ltd. on Valueinvestorsclub.com by zamperini. In this article, we will ...

REVEAL GENOMICS, S.L., a Barcelona-based biotechnology company focused on advancing precision oncology through biomarker ...

Replicate Bioscience & Instituto Butantan ink collaboration to develop and commercialize Replicate’s srRNA rabies vaccine in Latin America: San Diego, California Monday, Decembe ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

It’s about co-creating science.” The event highlighted pathogen research discoveries and pandemic prevention efforts from ...

Presented new data in non-human primates (NHP) for sickle cell disease (SCD), where RNA Gene Writer achieved approximately 40% and 60% of long-term hematopoietic stem cells (LT-HSCs) with at least one ...

An announcement from Sarepta Therapeutics ( ($SRPT) ) is now available. On December 7, 2025, Sarepta Therapeutics‘ Board of Directors granted ...

As of Monday, December 08, Camp4 Therapeutics Corporation’s CAMP share price has surged by 13.54%, which has investors questioning if this is right time to sell.

Carnavale has flown under the radar, but resources expert John Forwood says the junior goldie makes the grade when it comes ...